Detecting polyagglutinable red blood cells

1. Sharon N, Lis H. History of lectins: from hemagglutinins to biological recognition molecules. Glycobiology 2004;14: 53R–62R.10.1093/glycob/cwh122 Search in Google Scholar

2. Gorakshakar AC, Ghosh K. Use of lectins in immunohematology. Asian J Transfus Sci 2016;10:12–21.10.4103/0973-6247.172180 Search in Google Scholar

3. Hubener G. Investigation of isoagglutination, with special consideration of apparent deviations from the blood grouping scheme. [In German] Z Immunitatsforsch 1926;45:223–48. Search in Google Scholar

4. Poulsen PE. Experimentally produced “polyagglutinability” (T-transformation of erythrocytes in vivo) in guinea pigs infected with pneumococci. Nature 1954;173:82–3.10.1038/173082b0 Search in Google Scholar

5. Crookston KP, Reiner AP, Cooper LJN, Sacher RA, Blajchman MA, Heddle NM. RBC T activation and hemolysis: implications for pediatric transfusion management. Transfusion 2000;40: 801–12.10.1046/j.1537-2995.2000.40070801.x Search in Google Scholar

6. Levine P, Katzin EM. Temporary agglutinability of red blood cells. Proc Soc Exp Biol NY 1938;39:167–9.10.3181/00379727-39-10133P Search in Google Scholar

7. Ramasethu J, Luban N. T Activation. Br J Haematol 2001;112: 259–63.10.1046/j.1365-2141.2001.02301.x Search in Google Scholar

8. Moh-Klaren J, Bodivit G, Jugie M, et al. Severe hemolysis after plasma transfusion in a neonate with necrotizing enterocolitis, Clostridium perfringens infection and red blood cell T-polyagglutination. Transfusion 2017;57:2571–7.10.1111/trf.14196 Search in Google Scholar

9. Gerbal A, Maslet C, Salmon C. Immunological aspects of the acquired-B antigen. Vox Sang 1975;28:398.10.1111/j.1423-0410.1975.tb02787.x Search in Google Scholar

10. Judd WJ, McGuire-Mallory D, Anderson KM, et al. Concomitant T- and Tk-activation association with acquired-B antigens. Transfusion 1979;19:293–8.10.1046/j.1537-2995.1979.19379204210.x Search in Google Scholar

11. Doinel C, Andreu G, Cartron JP, Salmon C, Fukuda MV. Tk polyagglutination produced by in vitro by an endo–beta– galacto–sidase. Vox Sang 1980;38:94–8. Search in Google Scholar

12. Bird GW, Wingham J, Beck ML, Pierce SR, Oates GD, Pollock A. Th, a “new” form of erythrocyte polyagglutinability. Lancet 1978;1:1215-6.10.1016/S0140-6736(78)91013-9 Search in Google Scholar

13. Bird GW, Windham J, Seger R, Kenny AB. Tx, a “new” red cell cryptantigen exposed by pneumococcal enzymes. Blood Transf Immunohaemat 1982;25215–16.10.1016/S0338-4535(82)80009-3 Search in Google Scholar

14. Suchanowska A, Kaczmarek R, Duk M, et al. A single point mutation in the gene encoding Gb3/CD77 synthase causes a rare inherited polyagglutination syndrome. J Biol Chem 2012;287:38220–30.10.1074/jbc.M112.408286 Search in Google Scholar

15. Reid ME, Lomas-Francis C, Olsson M. The blood group antigen factsbook. 3rd ed. San Diego, CA: Academic Press, 2012.10.1016/B978-0-12-415849-8.00006-5 Search in Google Scholar

16. Halverson GR, Lee AH, Oyen R, Reiss RF, Hurlet-Jensen A, Reid ME. Altered glycosylation leads to Tr polyagglutination. Transfusion 2004;44:1588–92.10.1111/j.0041-1132.2004.04133.x Search in Google Scholar

17. Mawby WJ, Tanner MJA, Anstee DJ, Clamp JR. Incomplete glycosylation of erythrocyte to membrane protein in congenital dyserythropoietic anemia Type II. (CDA II) Br Haematol 1983;55:357–68.10.1111/j.1365-2141.1983.tb01257.x Search in Google Scholar

18. Fukuda MN. HEMPAS: Hereditary erythroblastic multiniclearity with positive acidified serum lysis test. Biochim Biophys Acta 1999;1455:231–9.10.1016/S0925-4439(99)00070-8 Search in Google Scholar

19. Sanger R, Gavin J, Tippett P, Teesdale P, Eldon K. Plant agglutinin for another human blood-group. Lancet 1971;i:1130.10.1016/S0140-6736(71)91865-4 Search in Google Scholar

20. Pickles MM, Morton JA. The Sd^a blood group antigen. In: Human blood groups. 5th International Convocation on Immunology, Buffalo, NY, 1977:277–86. Search in Google Scholar

21. Sringarm S, Chiewsilp P, Tubrod J. Cad receptor in Thai blood donors. Vox Sang 1974;26:462–6.10.1111/j.1423-0410.1974.tb02721.x Search in Google Scholar

22. Bird GW, Wingham J, Pippard MJ, Hoult JG, Melikian V. Erythrocyte membrane modification in malignant diseases of myeloid and lymphoreticular tissues. I. Tn–polyagglutination in acute myelocytic leukaemia. Br J Haematol 1976;33: 289–94.10.1111/j.1365-2141.1976.tb03540.x Search in Google Scholar

23. Cartron JP, Cartron J, Andreu G, et al. Selective deficiency of 3-B-galactosyl-transferase (T-transferase) in Tn-polyagglutinable erythrocytes. Lancet 1978;i:856–7.10.1016/S0140-6736(78)90197-6 Search in Google Scholar

24. Beck ML. Tn: a nonmicrobial form of polyagglutination. In: Beck ML, Judd WJ, Eds. Polyagglutination. Washington, DC: AABB, 1980:55–70. Search in Google Scholar

25. Schulz M, Fortes P, Brewer L, et al. “In Utero” exposure of Tn and Th cryptantigens (abstract). Transfusion 1983;23:422. Search in Google Scholar

26. Judd WJ. Judd’s methods in immunohematology. 3rd ed. Durham, NC: Montgomery Scientific Publications, 2008. Search in Google Scholar

27. Judd WJ. Review: polyagglutination. Immunohematology 1992;8:58–69.10.21307/immunohematology-2019-986 Search in Google Scholar

28. Judd, WJ. The use of purified lectins in immunohematology. Transfusion 1979;19:769–9.10.1046/j.1537-2995.1979.19680104107.x524434 Search in Google Scholar

29. King MJ, Liew YW, Moores PP, Bird GWG. Enhanced reaction with Vicia graminea lectin and exposed terminal N-acetyl-D-glucosaminyl residues on a sample of human red cells with Hb M-Hyde Park. Transfusion 1988;28:549–55.10.1046/j.1537-2995.1988.28689059029.x3143169 Search in Google Scholar

30. Mollison PL, Engelfriet CP, Contreras M. Blood transfusion in clinical medicine. 10th ed. Oxford, UK: Blackwell Science, 1997. Search in Google Scholar

31. Issitt PD. Applied blood group serology. 3rd ed. Miami, FL: Montgomery Scientific iPublications, 1985:457. Search in Google Scholar

32. Hemo bioscience. Lectin package insert. Version 2.1 Revised 03-2015. Morrisville, NC: Hemo bioscience. Search in Google Scholar